StonvexLoading…
StonvexStonvexStonvexCore line items from BXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $801.66M | $731.15M | $2.95B | $2.24B | $1.49B |
Operating Income | Not available | $7.33M | $32.48M | $35.73M | $25.76M |
Net Income | Not available | $-1.46M | $219.00K | $8.77M | $4.31M |
EPS (Diluted) | $0.30 | $-0.18 | $0.02 | $1.08 | $0.87 |
Total Assets | Not available | $1.60B | $1.55B | $1.58B | $1.58B |
Total Liabilities | Not available | $982.54M | $931.96M | $958.95M | $962.72M |
Cash & Equivalents | Not available | $319.09M | $385.84M | $429.36M | $386.76M |
Free Cash Flow OCF − CapEx | Not available | $-59.83M | $32.85M | $-23.54M | $-76.20M |
Shares Outstanding | Not available | 7.82M | 7.87M | 7.86M | 7.88M |